Tower Research Capital (TRC)’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,353
| Closed | -$8.93K | – | 6162 |
|
|
2024
Q2 | $8.93K | Buy |
1,353
+631
| +87% | +$4.16K | ﹤0.01% | 4303 |
|
|
2024
Q1 | $7.94K | Sell |
722
-1
| -0.1% | -$11 | ﹤0.01% | 4110 |
|
|
2023
Q4 | $9.76K | Buy |
723
+702
| +3,343% | +$9.48K | ﹤0.01% | 4347 |
|
|
2023
Q3 | $445 | Sell |
21
-45
| -68% | -$954 | ﹤0.01% | 5561 |
|
|
2023
Q2 | $2.53K | Buy |
66
+14
| +27% | +$536 | ﹤0.01% | 5166 |
|
|
2023
Q1 | $1K | Sell |
52
-192
| -79% | -$3.69K | ﹤0.01% | 5733 |
|
|
2022
Q4 | $8K | Buy |
244
+202
| +481% | +$6.62K | ﹤0.01% | 4519 |
|
|
2022
Q3 | $5K | Buy |
42
+5
| +14% | +$595 | ﹤0.01% | 5214 |
|
|
2022
Q2 | $7K | Sell |
37
-113
| -75% | -$21.4K | ﹤0.01% | 4873 |
|
|
2022
Q1 | $44K | Buy |
150
+94
| +168% | +$27.6K | ﹤0.01% | 2844 |
|
|
2021
Q4 | $29K | Sell |
56
-7
| -11% | -$3.63K | ﹤0.01% | 3284 |
|
|
2021
Q3 | $24K | Buy |
63
+13
| +26% | +$4.95K | ﹤0.01% | 3579 |
|
|
2021
Q2 | $44K | Buy |
50
+16
| +47% | +$14.1K | ﹤0.01% | 3138 |
|
|
2021
Q1 | $41K | Sell |
34
-20
| -37% | -$24.1K | ﹤0.01% | 3302 |
|
|
2020
Q4 | $72K | Buy |
54
+51
| +1,700% | +$68K | ﹤0.01% | 2701 |
|
|
2020
Q3 | $6K | Buy |
+3
| New | +$6K | ﹤0.01% | 4325 |
|